Interim guidance on clinical management of Mpox (Monkeypox) 2079 (2022)

Interim guidance on clinical management of Mpox (Monkeypox) 2079 (2022)

Table of Contents (toc)

Mpox interim guideline NEpal

Monkeypox is a viral zoonotic disease caused by the monkeypox virus, which belongs to the Orthopoxvirus genus, the same group as smallpox. It is primarily found in Central and West Africa but has been increasingly reported in other regions, highlighting its potential to spread beyond endemic areas. The virus is transmitted to humans through close contact with an infected animal, human, or contaminated materials. 

Symptoms

 Symptoms typically include fever, rash, and swollen lymph nodes, often resembling smallpox but generally less severe. While most cases are mild and self-limiting, severe cases can occur, particularly in immunocompromised individuals or those with comorbidities.

Vaccination

Vaccination against smallpox offers some protection against monkeypox, and public health efforts are focused on surveillance, early diagnosis, and containment to prevent outbreaks.

Please go through the  Mpox (Monkeypox) pdf below: 

Thank you.

Read more on Mpox here

Download the Interim guidance on clinical management of Mpox (Monkeypox) 2079 (2022)